Home » Topics » Regulatory » Patents

Patents
RSS

Selective dopamine D3 receptor ligands from Novo Nordisk

June 26, 1997

Ono describes elastase inhibitors

June 26, 1997

P&U prepares inhibitors of kynurenine 3-hydroxylase for neurodegenerative diseases

June 26, 1997

Kyowa Hakko claims compounds for thrombocytopenia

June 26, 1997

Novel melatonergic agents described by Bristol-Myers Squibb

June 26, 1997

5-HT1B receptor antagonists claimed by SKB

June 25, 1997

Centrally active muscarinic agents from American Home Products

June 25, 1997

NOS inhibitors disclosed by Astra for stroke and other disorders

June 25, 1997

New erythromycin derivatives from Abbott

June 25, 1997

Boehringer Ingelheim discloses tachykinin antagonists

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...